USPTO serial 79456615
Reviewed by CopyMark Law Group
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of neurological autoimmune diseases | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 25, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 20, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |